Surgery for Cancer: A Trigger for Metastases
Reads0
Chats0
TLDR
The role of perioperative factors, including anesthesia, transfusions, hypothermia, and postoperative complications, as probable deleterious factors contributing to early recurrence are addressed.Abstract:
Surgery is a crucial intervention and provides a chance of cure for patients with cancer. The perioperative period is characterized by an increased risk for accelerated growth of micrometastatic disease and increased formation of new metastatic foci. The true impact for cancer patients remains unclear. This review summarizes the often fragmentary clinical and experimental evidence supporting the role of surgery and inflammation as potential triggers for disease recurrence. Surgery induces increased shedding of cancer cells into the circulation, suppresses antitumor immunity allowing circulating cells to survive, upregulates adhesion molecules in target organs, recruits immune cells capable of entrapping tumor cells, and induces changes in the target tissue and in the cancer cells themselves to enhance migration and invasion to establish at the target site. Surgical trauma induces local and systemic inflammatory responses that can also contribute to the accelerated growth of residual and micrometastatic disease. Furthermore, we address the role of perioperative factors, including anesthesia, transfusions, hypothermia, and postoperative complications, as probable deleterious factors contributing to early recurrence. Through the admittedly limited understanding of these processes, we will attempt to provide suggestions for potential new therapeutic approaches to target the protumorigenic perioperative window and ultimately improve long-term oncological outcomes. Cancer Res; 77(7); 1548-52. ©2017 AACR.read more
Citations
More filters
Journal ArticleDOI
NF-κB, inflammation, immunity and cancer: coming of age
Koji Taniguchi,Michael Karin +1 more
TL;DR: How the initial discovery of a role for NF-κB in linking inflammation and cancer led to an improved understanding of tumour-elicited inflammation and its effects on anticancer immunity is discussed.
Journal ArticleDOI
Systemic immunity in cancer
TL;DR: In this paper, the authors comprehensively outline the current knowledge of systemic immunity in cancer, and show that new immune responses in individuals burdened with tumours are compromised even beyond the TME.
Journal ArticleDOI
Localized Interleukin-12 for Cancer Immunotherapy.
Khue G. Nguyen,Maura R. Vrabel,Siena M. Mantooth,Jared J. Hopkins,Ethan S. Wagner,Taylor A. Gabaldon,David A. Zaharoff +6 more
TL;DR: Diverse IL-12 delivery systems, from immunocytokine fusions to polymeric nanoparticles, have demonstrated robust antitumor immunity with reduced adverse events in preclinical studies, and diverse localized delivery approaches have recently reached the clinical stage with several more at the precipice of translation.
Journal ArticleDOI
Engineering PD-1-Presenting Platelets for Cancer Immunotherapy.
Xudong Zhang,Xudong Zhang,Xudong Zhang,Jinqiang Wang,Jinqiang Wang,Zhaowei Chen,Quanyin Hu,Chao Wang,Junjie Yan,Gianpietro Dotti,Peng Huang,Zhen Gu,Zhen Gu +12 more
TL;DR: This work genetically engineered platelets from megakaryocyte progenitor cells to express the programmed cell death protein 1 (PD-1) and found that the PD-1 platelet and its derived microparticle could accumulate within the tumor surgical wound and revert exhausted CD8+ T cells, leading to the eradication of residual tumor cells.
Journal ArticleDOI
Sandwich‐Like Fibers/Sponge Composite Combining Chemotherapy and Hemostasis for Efficient Postoperative Prevention of Tumor Recurrence and Metastasis
Zhiyun Zhang,Gaizhen Kuang,Gaizhen Kuang,Shan Zong,Shi Liu,Haihua Xiao,Xuesi Chen,Dongfang Zhou,Yubin Huang +8 more
TL;DR: The obtained implantable CFSC is able to simultaneously stop bleeding and absorb disseminated tumor cells after tumor resection, which significantly inhibits local tumor recurrence and distant tumor metastasis on the subcutaneous postoperative recurrence model and metastasis models.
References
More filters
Journal ArticleDOI
Cancer statistics, 2015.
TL;DR: The overall cancer death rate decreased from 215.1 (per 100,000 population) in 1991 to 168.7 in 2011, a total relative decline of 22%.
Journal ArticleDOI
Dissemination and growth of cancer cells in metastatic sites
TL;DR: Inhibition of the growth of metastases in secondary sites offers a promising approach for cancer therapy and could help to improve the treatment of metastatic disease.
Journal ArticleDOI
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability.
TL;DR: This work surmises that CRI represents the seventh hallmark of cancer, and suggests that an additional mechanism involved in cancer-related inflammation (CRI) is induction of genetic instability by inflammatory mediators, leading to accumulation of random genetic alterations in cancer cells.
Journal ArticleDOI
Perioperative Normothermia to Reduce the Incidence of Surgical-Wound Infection and Shorten Hospitalization
TL;DR: Maintaining normothermia intraoperatively is likely to decrease the incidence of infectious complications in patients undergoing colorectal resection and to shorten their hospitalizations.
Journal ArticleDOI
Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
Jonathan Cools-Lartigue,Jonathan Spicer,Braedon McDonald,Stephen Gowing,Simon C. Chow,Betty Giannias,Paul Kubes,Lorenzo E. Ferri +7 more
TL;DR: It is reported that circulating tumor cells become trapped within NETs in vitro under static and dynamic conditions and NETs are identified as potential therapeutic targets in the context of systemic infection.